Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Neurosci Res ; 56(3): 279-85, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16934894

RESUMO

N-Methyl-d-aspartate (NMDA) receptors, which play an important role in neuronal excitotoxicity, require not only agonists at the glutamate-binding site but also co-agonists at the glycine site for their activation. Here we examined the role of endogenous agonists at the glycine site of NMDA receptors in excitotoxic retinal damage in vivo. To quantify the number of surviving retinal ganglion cells (RGCs), we injected a retrograde tracer, fluoro-gold, into the superior colliculus bilaterally and subsequently counted RGCs on whole-mounted retinas. Co-injection of 5,7-dichlorokynurenic acid (300 nmol), a competitive antagonist at the glycine site of NMDA receptors, rescued RGCs from damage induced by 200 nmol NMDA. On the other hand, RGC death induced by 20 nmol NMDA was enhanced by addition of glycine (10 nmol), D-serine (10 nmol) or a competitive glycine transporter-1 inhibitor, sarcosine (0.3 or 3 nmol). Moreover, application of d-serine-degrading enzyme, D-amino acid oxidase (30 mU), partially suppressed RGC death induced by 20 nmol NMDA. These results suggest that the severity of excitotoxic retinal damage in vivo depends on the levels of both glycine and D-serine.


Assuntos
Agonistas de Aminoácidos Excitatórios , Glicina/fisiologia , Receptores de N-Metil-D-Aspartato/metabolismo , Doenças Retinianas/induzido quimicamente , Células Ganglionares da Retina/efeitos dos fármacos , Amidoidrolases/farmacologia , Animais , Morte Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Interações Medicamentosas , Antagonistas de Aminoácidos Excitatórios/farmacologia , Ácido Cinurênico/análogos & derivados , Ácido Cinurênico/farmacologia , Masculino , N-Metilaspartato/farmacologia , Ratos , Ratos Sprague-Dawley , Doenças Retinianas/patologia , Serina/farmacologia
2.
J Pharmacol Sci ; 92(4): 428-32, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12939529

RESUMO

We compared the degree of neurotoxic outcome in the retina exposed to three nitric oxide (NO) donors with different half-life of NO release. Intravitreal injection of NO donors resulted in a significant decrease in cell density in the ganglion cell layer and thinning of the inner plexiform layer in a half-life time-dependent manner. Concurrent injection of an NO-trapping reagent with an NO donor abolished NO donor-induced retinal damage. (+)-MK-801 also prevented NO-induced retinal damage, indicating that N-methyl-D-aspartate receptors are partly involved in NO-induced neurodegeneration. These results may be relevant to a pathogenic role of NO - glutamate receptor in several ophthalmic disorders.


Assuntos
Doadores de Óxido Nítrico/toxicidade , Óxido Nítrico/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Retina/efeitos dos fármacos , Retina/patologia , Animais , Meia-Vida , Masculino , Doadores de Óxido Nítrico/farmacocinética , Compostos Nitrosos/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores de N-Metil-D-Aspartato/antagonistas & inibidores , Retina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA